Tylenol Maker, Pharmacy Chains Ask U.S. Appeals Court to Reconsider Ruling Reviving Autism-Related Lawsuits
Kenvue, the manufacturer of Tylenol, and several major pharmacy chains have filed a petition asking a U.S. appeals court to reconsider a decision in litigation over claims that prenatal exposure to acetaminophen causes autism spectrum disorder and attention-deficit/hyperactivity disorder, according to court documents. The petition was filed on Sept. 11, 2026, according to Reuters. The companies argue that the panel decision conflicts with federal law and prior rulings, the filing stated.
Read Full Article: https://www.naturalnews.com/2026-09-15-tylenol-maker-pharmacy-chains-ask-reconsider-autism-lawsuits.html
